Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bostwick

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology|March 13, 2010
Effect of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasisWilliam A Schumacher, Jeffrey S Bostwick, Anne B Stewart, et al.
Thrombosis and Haemostasis|November 19, 1997
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary arteryR J Leadley, C J Kasiewski, J S Bostwick, et al.
Thrombosis Research|January 19, 2007
Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?Eileen Bird, James Tamura, Jeffrey S Bostwick, et al.
Journal of Cardiovascular Pharmacology|May 22, 2007
Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
European Journal of Pharmacology|June 29, 2007
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in ratsWilliam A Schumacher, Steven E Seiler, Thomas E Steinbacher, et al.
Human Gene Therapy|March 18, 2016
Allele-Specific Quantitative PCR for Accurate, Rapid, and Cost-Effective GenotypingHan B Lee, Tanya L Schwab, Alaa Koleilat, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2007
Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in ratsWilliam A Schumacher, Jeffrey S Bostwick, Martin L Ogletree, et al.
Thrombosis Research|June 15, 1996
Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonistJ S Bostwick, C J Kasiewski, V Chu, et al.
Thrombosis Research|May 23, 2001
Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogsS S Rebello, C J Kasiewski, R G Bentley, et al.
Thrombosis and Haemostasis|May 29, 1999
RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbitJ S Bostwick, R Bentley, S Morgan, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|March 13, 2010
Effect of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasisWilliam A Schumacher, Jeffrey S Bostwick, Anne B Stewart, et al.
Thrombosis and Haemostasis|November 19, 1997
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary arteryR J Leadley, C J Kasiewski, J S Bostwick, et al.
Thrombosis Research|January 19, 2007
Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?Eileen Bird, James Tamura, Jeffrey S Bostwick, et al.
Journal of Cardiovascular Pharmacology|May 22, 2007
Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
European Journal of Pharmacology|June 29, 2007
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in ratsWilliam A Schumacher, Steven E Seiler, Thomas E Steinbacher, et al.
Human Gene Therapy|March 18, 2016
Allele-Specific Quantitative PCR for Accurate, Rapid, and Cost-Effective GenotypingHan B Lee, Tanya L Schwab, Alaa Koleilat, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2007
Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in ratsWilliam A Schumacher, Jeffrey S Bostwick, Martin L Ogletree, et al.
Thrombosis Research|June 15, 1996
Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonistJ S Bostwick, C J Kasiewski, V Chu, et al.
Thrombosis Research|May 23, 2001
Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogsS S Rebello, C J Kasiewski, R G Bentley, et al.
Thrombosis and Haemostasis|May 29, 1999
RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbitJ S Bostwick, R Bentley, S Morgan, et al.
Pageof 4